|
Jun 13
|
GSK (LSE:GSK) Seeks European Expansion Of RSV Vaccine To Adults 18 And Older
|
|
Jun 11
|
Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel
|
|
Jun 10
|
Vaccine Stocks Mixed After RFK Jr. Fires CDC's Entire Vaccine Committee
|
|
Apr 10
|
GSK (LSE:GSK) Sees 6% Share Price Decline Over The Last Quarter
|
|
Apr 9
|
GSK Awards $2M in Grant Funding for Programs Supporting Adult Vaccination, Commits Additional $2M for 2025
|
|
Apr 9
|
Trending tickers: Apple, Advanced Micro Devices, Ford, BP and AstraZeneca
|
|
Feb 17
|
GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) Q3 2025 Earnings Call Highlights: Strong ...
|
|
Feb 15
|
GSK shares shorted by leading U.S. hedge fund, The Times reports
|
|
Feb 15
|
Here's Why We're Wary Of Buying GSK's (LON:GSK) For Its Upcoming Dividend
|
|
Feb 14
|
Hedge fund Citadel takes short position in GSK, FT reports
|
|
Feb 13
|
ViiV Healthcare and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully finalize negotiations for APRETUDE for HIV-1 Pre-Exposure Prophylaxis
|
|
Feb 12
|
Some May Be Optimistic About GSK's (LON:GSK) Earnings
|
|
Feb 11
|
Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty
|
|
Feb 10
|
Recent uptick might appease GSK plc (LON:GSK) institutional owners after losing 7.8% over the past year
|
|
Jan 4
|
GSK’s Nucala Gains Approval in China for CRSwNP
|
|
Jan 3
|
GSK's Sinus Disease Drug Secures Approval In China
|
|
Dec 30
|
Can GSK plc (LON:GSK) Maintain Its Strong Returns?
|
|
Sep 30
|
GSK plc (NYSE:GSK) Doesn’t Rank Too High In The List Of The Best Global Stocks To Buy
|
|
Jul 24
|
GSK (GSK) Earnings Expected to Grow: Should You Buy?
|
|
Jun 16
|
The $3bn crisis casting a shadow over Dame Emma Walmsley’s GSK
|